• Immunogenicity Assessment

    • Therapeutic In Silico Services
      • ISPRIâ„¢ Website
      • ISPRI Downselectâ„¢
      • ISPRI Quantifyâ„¢
      • ISPRI Analyzeâ„¢
      • ISPRI Evaluateâ„¢
      • ISPRI-HCPâ„¢
      • ISPRI Designâ„¢
      • PANDA® Screening
    • Vaccine In Silico Services
      • iVAXâ„¢
      • EpiCCâ„¢
      • Ancer®
      • PreVAXâ„¢
    • Lab Services
      • HLA Binding Assay
      • T Cell Assay
      • Innate Assay
    • Consulting Services
  • About Us
    • Leadership
    • Careers
  • Partner
  • Press
    • News
    • Events
    • Publications
    • Blog
  • Contact Us
Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences

Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences

by Adam | Oct 22, 2016

Vaccine 1995, Vol. 13, No. 6, pp. 581-591.
Prediction of HIV peptide epitopes by a novel algorithm

Prediction of HIV peptide epitopes by a novel algorithm

by Adam | Oct 22, 2016

AIDS Research and Human Retroviruses, 1996, Vol. 12, No. 7, pp. 593-610.
An interactive Web site providing major histocompatibility ligand predictions: application to HIV research

An interactive Web site providing major histocompatibility ligand predictions: application to HIV research

by Adam | Oct 22, 2016

AIDS Res Hum Retroviruses. 1997 May 1; 13(7):529-31.
Prediction of well-conserved HIV-1 ligands using a Matrix-based Algorithm, EpiMatrix

Prediction of well-conserved HIV-1 ligands using a Matrix-based Algorithm, EpiMatrix

by Adam | Oct 22, 2016

Vaccine, 1998, Vol. 16, No. 19, pp. 1880-1884.
Identification of subdominant cytotoxic T lymphocyte epitopes encoded by autologous  HIV type 1 sequences, using dendritic cell stimulation and computer-driven algorithm

Identification of subdominant cytotoxic T lymphocyte epitopes encoded by autologous HIV type 1 sequences, using dendritic cell stimulation and computer-driven algorithm

by Adam | Oct 22, 2016

IDS Res Hu Retroviruses Vol 16, No.1, pp. 67-76, January 2000.
« Older Entries

Recent Posts

  • BEBPA Workshop: Streamlining Immunogenicity Assessment of Host Cell Proteins
  • Advancing Immunogenicity Science: EpiVax in 2025 
  • EpiVax Supports Life-Saving Programs Through Partnerships with GAIA Vaccine Foundation and Clínica Esperanza/Hope Clinic
  • EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide
  • Doing Well and Giving Back in December

Recent Comments

No comments to show.

Join our newsletter

Stay up to date with EpiVax and greater industry news, events, and technological advancements with this monthly update written by EpiVax co-founder and CMO, Dr. Annie De Groot.

Explore

Therapeutic In Silico Services

Vaccine In Silico Services

Lab Services

Consulting

LinkedIn

About Us

Careers

Partner

News

Events

Publications

Contact Us

We use cookies to ensure that we give you the best experience on our website. By clicking 'accept', you consent to our use of cookies.